The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells
Open accessAbstract
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has dramatically changed our world, country, communities, and families. There is controversy regarding risk factors for severe COVID-19 disease. It has been suggested that asthma and allergy are not highly represented as comorbid conditions associated with COVID-19. Objective Our aim was to extend our work in IL-13 biology to determine whether airway epithelial cell expression of 2 key mediators critical for SARS-CoV-2 infection, namely, angiotensin-converting enzyme 2 (ACE2) and transmembrane protease, serine 2 (TMPRSS2), are modulated by IL-13. Methods We determined effects of IL-13 treatment on ACE2 and TMPRSS2 expression ex vivo in primary airway epithelial cells from participants with and without type 2 asthma obtained by bronchoscopy. We also examined expression of ACE2 and TMPRSS2 in 2 data sets containing gene expression data from nasal and airway epithelial cells from children and adults with asthma and allergic rhinitis. Results IL-13 significantly reduced ACE2 and increased TMPRSS2 expression ex vivo in airway epithelial cells. In 2 independent data sets, ACE2 expression was significantly reduced and TMPRSS2 expression was significantly increased in the nasal and airway epithelial cells in type 2 asthma and allergic rhinitis. ACE2 expression was significantly negatively associated with type 2 cytokines, whereas TMPRSS2 expression was significantly positively associated with type 2 cytokines. Conclusion IL-13 modulates ACE2 and TMPRSS2 expression in airway epithelial cells in asthma and atopy. This deserves further study with regard to any effects that asthma and atopy may render in the setting of COVID-19 infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,994
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma
Program, P., & theDiagnosis, T. E. P. O. (1997) · Cited by 4,926
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
Bhatraju, P. K., Ghassemieh, B. J., Nichols, M., Kim, R., Jerome, K. R., Nalla, A. K., Greninger, A. L., Pipavath, S., Wurfel, M. M., Evans, L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004500 · Cited by 2,583
Garg, S., Kim, L., Whitaker, M., O’Halloran, A., Cummings, C., Holstein, R., Prill, M., Chai, S. J., Kirley, P. D., Alden, N. B., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6915e3 · Cited by 2,335
T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0392oc · Cited by 1,803
Woodruff, P. G., Boushey, H. A., Dolganov, G. M., Barker, C. S., Yang, Y. H., Donnelly, S., Ellwanger, A., Sidhu, S. S., Dao-Pick, T. P., Pantoja, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707413104 · Cited by 828
Hofmann, H., Pyrc, K., van der Hoek, L., Geier, M., Berkhout, B., & Pöhlmann, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409465102 · Cited by 824
Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
Bousquet, J., Schünemann, H. J., Samolinski, B., Demoly, P., Baena-Cagnani, C. E., Bachert, C., Bonini, S., Boulet, L. P., Bousquet, P. J., Brozek, J. L., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.053 · Cited by 623
Self-citationIwata-Yoshikawa, N., Okamura, T., Shimizu, Y., Hasegawa, H., Takeda, M., & Nagata, N. (2019) · Journal of Virology · doi:10.1128/jvi.01815-18 · Cited by 618
Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2
Jackson, D. J., Busse, W. W., Bacharier, L. B., Kattan, M., O’Connor, G. T., Wood, R. A., Visness, C. M., Durham, S. R., Larson, D., Esnault, S., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.009 · Cited by 568
Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
Batlle, D., Wysocki, J., & Satchell, K. (2020) · Clinical Science · doi:10.1042/cs20200163 · Cited by 444
Bertram, S., Heurich, A., Lavender, H., Gierer, S., Danisch, S., Perin, P., Lucas, J. M., Nelson, P. S., Pöhlmann, S., & Soilleux, E. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035876 · Cited by 398
Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?
Halpin, D. M. G., Faner, R., Sibila, O., Badia, J. R., & Agusti, A. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30167-3 · Cited by 385
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge
Lupia, T., Scabini, S., Mornese Pinna, S., Di Perri, G., De Rosa, F. G., & Corcione, S. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2020.02.021 · Cited by 364
Bertram, S., Dijkman, R., Habjan, M., Heurich, A., Gierer, S., Glowacka, I., Welsch, K., Winkler, M., Schneider, H., Hofmann-Winkler, H., et al. (2013) · Journal of Virology · doi:10.1128/jvi.03372-12 · Cited by 350
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y., Lu, X., Zhang, J., Du, H., Yan, Y., Akdis, C. A., & Gao, Y. (2020) · Allergy · doi:10.1111/all.14289 · Cited by 347
Wösten‐van Asperen, R. M., Lutter, R., Specht, P. A., Moll, G. N., van Woensel, J. B., van der Loos, C. M., van Goor, H., Kamilic, J., Florquin, S., & Bos, A. P. (2011) · The Journal of Pathology · doi:10.1002/path.2987 · Cited by 304
Matsuyama, S., Kawase, M., Nao, N., Shirato, K., Ujike, M., Kamitani, W., Shimojima, M., & Fukushi, S. (2020) · Journal of Virology · doi:10.1128/jvi.01648-20 · Cited by 287
Accumulation of intraepithelial mast cells with a unique protease phenotype in TH2-high asthma
Dougherty, R. H., Sidhu, S. S., Raman, K., Solon, M., Solberg, O. D., Caughey, G. H., Woodruff, P. G., & Fahy, J. V. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.03.003 · Cited by 254
TMPRSS2 and TMPRSS4 Facilitate Trypsin-Independent Spread of Influenza Virus in Caco-2 Cells
Bertram, S., Glowacka, I., Blazejewska, P., Soilleux, E., Allen, P., Danisch, S., Steffen, I., Choi, S.-Y., Park, Y., Schneider, H., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00239-10 · Cited by 205
Balakumar, P., & Jagadeesh, G. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.06.011 · Cited by 182
Limburg, H., Harbig, A., Bestle, D., Stein, D. A., Moulton, H. M., Jaeger, J., Janga, H., Hardes, K., Koepke, J., Schulte, L., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00649-19 · Cited by 170
Sakai, K., Ami, Y., Tahara, M., Kubota, T., Anraku, M., Abe, M., Nakajima, N., Sekizuka, T., Shirato, K., Suzaki, Y., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03677-13 · Cited by 165
Pieruzzi, F., Abassi, Z. A., & Keiser, H. R. (1995) · Circulation · doi:10.1161/01.cir.92.10.3105 · Cited by 153
de Lang, A., Osterhaus, A. D. M. E., & Haagmans, B. L. (2006) · Virology · doi:10.1016/j.virol.2006.06.011 · Cited by 134
Magalhães, G. S., Rodrigues‐Machado, M. D. G., Motta‐Santos, D., Silva, A. R., Caliari, M. V., Prata, L. O., Abreu, S. C., Rocco, P. R. M., Barcelos, L. S., Santos, R. A. S., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13057 · Cited by 101
Mycoplasma pneumoniaeinduces airway epithelial cell expression of MUC5AC in asthma
Kraft, M., Adler, K. B., Ingram, J. L., Crews, A. L., Atkinson, T. P., Cairns, C. B., Krause, D. C., & Chu, H. W. (2007) · European Respiratory Journal · doi:10.1183/09031936.00103307 · Cited by 99
Self-citationDistinct epithelial gene expression phenotypes in childhood respiratory allergy
Giovannini‐Chami, L., Marcet, B., Moreilhon, C., Chevalier, B., Illie, M. I., Lebrigand, K., Robbe-Sermesant, K., Bourrier, T., Michiels, J., Mari, B. P., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00070511 · Cited by 86
Distinct Roles of FOXA2 and FOXA3 in Allergic Airway Disease and Asthma
Park, S., Verhaeghe, C., Nguyenvu, L. T., Barbeau, R., Eisley, C. J., Nakagami, Y., Huang, X., Woodruff, P. G., Fahy, J. V., & Erle, D. J. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200811-1768oc · Cited by 81
Saraya, T., Kurai, D., Ishii, H., Ito, A., Sasaki, Y., Niwa, S., Kiyota, N., Tsukagoshi, H., Kozawa, K., Goto, H., et al. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00226 · Cited by 57
Sakai, K., Sekizuka, T., Ami, Y., Nakajima, N., Kitazawa, M., Sato, Y., Nakajima, K., Anraku, M., Kubota, T., Komase, K., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00124-15 · Cited by 35
Cited by
Risk factors for severe and critically ill COVID‐19 patients: A review
Gao, Y., Ding, M., Dong, X., Zhang, J., Kursat Azkur, A., Azkur, D., Gan, H., Sun, Y., Fu, W., Li, W., et al. (2021) · Allergy · doi:10.1111/all.14657 · Cited by 1,402
Bousquet, J., Anto, J. M., Bachert, C., Baiardini, I., Bosnic-Anticevich, S., Walter Canonica, G., Melén, E., Palomares, O., Scadding, G. K., Togias, A., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00227-0 · Cited by 942
Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality
Zhang, J.-J., Dong, X., Liu, G.-H., & Gao, Y.-D. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-022-08921-5 · Cited by 715
Zhu, Z., Lian, X., Su, X., Wu, W., Marraro, G. A., & Zeng, Y. (2020) · Respiratory Research · doi:10.1186/s12931-020-01479-w · Cited by 614
ACE2: The Major Cell Entry Receptor for SARS-CoV-2
Scialo, F., Daniele, A., Amato, F., Pastore, L., Matera, M. G., Cazzola, M., Castaldo, G., & Bianco, A. (2020) · Lung · doi:10.1007/s00408-020-00408-4 · Cited by 481
Metadata
- Authors
- Kimura, H., Francisco, D., Conway, M., Martinez, F. D., Vercelli, D., Polverino, F., Billheimer, D., & Kraft, M.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 146
- Issue
- 1
- Pages
- 80-88.e8
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W3024168867
- Cited by
- 340
- References
- 37
- FWCI
- 34.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.